文献速递主动脉疾病

肌少症可预测EVAR术后死亡与不良结局并用于风险分层

Sarcopenia predicts mortality and adverse outcomes after endovascular aneurysm repair and can be used to risk stratify patients.
PubMed 文献 · J Vasc Surg · 2019-03-07

该单中心回顾性研究纳入2002年9月至2014年6月接受择期EVAR的272例患者,基于术前CT测量第三腰椎水平双侧腰大肌面积并归一化(nTPA)评估肌少症。

要点

  • 肌少症可从术前CT扫描便捷评估,无需额外检查。
  • nTPA最低四分位组总体死亡率显著高于其余四分位组。
  • 肌少症解释了EVAR术后1年生存模型57%的风险效应。

核心结论

  • 肌少症可协助识别EVAR术后不太可能获益的患者候选者。
  • 肌少症可从术前CT扫描便捷评估,或可用于腹主动脉瘤患者风险评估与远程医疗。

研究设计与样本

  • 单机构回顾性综述,纳入2002年9月至2014年6月所有接受择期EVAR且有围手术期CT扫描和临床数据的患者。
  • 共272例患者,其中237例男性、35例女性,中位年龄72岁,平均体重指数28.6 kg/m2。
  • 在轴位CT第三腰椎水平测量双侧腰大肌面积并除以患者身高平方得到归一化总腰大肌横截面积(nTPA),以受试者工作特征曲线确定肌少症最佳估计阈值。
  • 采用单变量、多变量和生存分析评估肌少症作为独立风险预测因子。

主要发现

  • nTPA最低四分位组总体死亡率显著升高(Q1 23.53%;Q2 13.24%;Q3 7.35%;Q4 5.88%;P=.01)。
  • EVAR术后死亡率增加的估计nTPA阈值为500 mm2/m2。
  • 使用该阈值时,肌少症解释了1年生存模型中57%的风险效应。

关键数值与推荐

  • nTPA最低四分位组总体死亡率23.53%。
  • nTPA第二四分位组总体死亡率13.24%。
  • nTPA第三四分位组总体死亡率7.35%。
  • nTPA第四四分位组总体死亡率5.88%。
  • EVAR术后死亡率增加的估计nTPA阈值为500 mm2/m2。

临床怎么用

  • 对EVAR候选者可利用术前CT测量nTPA筛查肌少症,辅助识别术后死亡风险较高、可能不太获益的患者。
  • 可将nTPA阈值500 mm2/m2作为风险分层参考,用于术前评估与远程医疗场景。

局限性

  • 单机构回顾性研究,结论可能受选择偏倚与中心经验影响。
  • 仅纳入有围手术期CT扫描和临床数据的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aneurysm repair (EVAR) is currently the most common treatment of abdominal aortic aneurysms. Potential predictors of long-term survival after EVAR include physiologic, functional, and cognitive status, but assessments of these conditions have been difficult to standardize. Objective radiographic findings, such as skeletal muscle atrophy, or sarcopenia, may provide an additional means for selection of patients. This study investigates sarcopenia as a method to predict 1-year survival in patients undergoing EVAR. METHODS: A single-institution retrospective review was conducted of all patients who underwent elective EVAR from September 2002 to June 2014. Patients with an available periprocedural computed tomography (CT) scan and clinical data were included in the analysis. Normalized total psoas cross-sectional area (nTPA) was measured on axial CT images using the area of the bilateral psoas muscle at the third lumbar vertebral level normalized to the square of patient height. A threshold for optimal estimate of sarcopenia based on nTPA was determined using a receiver operating characteristic curve. Sarcopenia was evaluated as an independent risk predictor using univariate, multivariate, and survival analysis. RESULTS: A total of 272 EVAR-treated patients were evaluated, including 237 men and 35 women with a median age of 72 years and mean body mass index of 28.6 kg/m2. There was a significant increase in overall mortality in patients in the lowest quartile of nTPA (Q1, 23.53%; Q2, 13.24%; Q3, 7.35%; Q4, 5.88%; P = .01). The estimated nTPA threshold for increased mortality after EVAR was 500 mm2/m2. Using this threshold, sarcopenia accounted for 57% of the risk effect in our 1-year survival model. CONCLUSIONS: Sarcopenia can assist in identifying EVAR candidates who are less likely to benefit from surgery. It can be readily evaluated from preoperative CT scans and may be a useful tool in evaluation of abdominal aortic aneurysm patients with applications in risk evaluation and telemedicine.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cheng BT, Soult MC, Helenowski IB, et al. Sarcopenia predicts mortality and adverse outcomes after endovascular aneurysm repair and can be used to risk stratify patients. J Vasc Surg. 2019. PMID: 30852041. doi:10.1016/j.jvs.2018.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。